Four-year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation.
Benjamin MiaoAdrian V HernandezYuani M RomanMark J AlbertsCraig I ColemanWilliam L BakerPublished in: Clinical cardiology (2020)
Comorbid AF carries a substantial risk of MACE in patients with or at risk of atherosclerotic disease. MACE risk increases with higher CHA2 DS2 -VASc scores and is more likely in patients without OAC.
Keyphrases
- atrial fibrillation
- cardiovascular events
- cardiovascular disease
- end stage renal disease
- coronary artery disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- heart failure
- oral anticoagulants
- left atrial
- left atrial appendage
- patient reported outcomes
- venous thromboembolism
- left ventricular
- adverse drug